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Abstract
Polybrominated diphenyl ethers (PBDEs) flame retardants (FRs) were phased-out in the 
mid-2000s (penta- and octaBDE) and 2013 (decaBDE); however, their hydroxylated metabolites 
(OH-BDEs) are still commonly detected in human serum. Today, novel FRs such as Firemaster® 
550, a mixture that contains two brominated compounds, EH-TBB and BEH-TEBP are used as 
replacements for PBDEs in some applications, and there is a need to develop a comprehensive 
analytical method to assess exposure to both legacy PBDEs and novel FRs. This study developed a 
solid-phase extraction (SPE)-based method to analyze PBDEs, OH-BDEs, 2,4,6-tribromophenol 
(TBP), hexabromocylcododecane isomers (HBCDs), EH-TBB, and BEH-TEBP in human serum. 
Briefly, serum proteins were first denatured with formic acid, and then the target analytes were 
isolated using a SPE column. Finally, the extract was cleaned and fractioned using a silica SPE 
column. Method performance was assessed by spiking fetal bovine serum with 1–2 ng of the target 
analytes, and method accuracy was quantified by comparison to a serum Standard Reference 
Material (SRM). The developed method showed good recovery and accuracy for all target analytes 
with the exception of the very low and very high molecular weight PBDE congeners. Using this 
method, 43 serum samples collected from the Healthy Pregnancy, Healthy Baby Study (HPHB) 
cohort in Durham, NC, USA were analyzed for FRs. A novel finding was the ubiquitous detection 
of 2,4, 6-TBP, at levels greater than the individual PBDE congeners. Furthermore, 2,4,6-TBP was 
positively correlated with PBDEs, suggesting that they may have a similar source of exposure, or 
that 2,4,6-TBP may result from metabolism of PBDEs in vivo.
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Introduction
Chemical flame retardants (FRs) are used in foams, polymers, and textiles to prevent 
combustion and suppress fire propagation. Due to strict fire safety regulations, FRs are 
broadly found in commercial products such as furniture, electronics, and construction 
material. Prior to the mid-2000s, one of the most common classes of FRs was the 
polybrominated diphenyl ethers (PBDEs). PBDEs were sold primarily as either penta-, 
octa-, or decaBDE commercial mixtures. Due to concerns regarding their persistence and 
human health effects, pentaBDE and octaBDE mixtures were banned in both Europe and the 
USA during the mid-2000s. Further, pentaBDE and octaBDE mixtures are now listed as 
persistent organic pollutants under Annex A of the Stockholm Convention [1]. In addition, 
the decaBDE mixture was phased-out by the end of 2013 [2]. Despite these phase-outs, 
PBDEs are still commonly detected in household furniture [3] and in house dust samples [4, 
5]. PBDEs and their hydroxylated metabolites are also still widely detected in human serum 
[6–8]. For example, in the most recent NHANES data (2007–2008) BDE 28, 47, 99, 100, 
and 153 were detected in 100 % of the pooled samples.
In response to PBDE regulatory bans, the chemical flame retardant market has shifted to 
alternative, and sometimes novel, compound classes. Among these novel FRs is Firemaster 
550® (FM550), which is a mixture of two brominated compounds [2-ethylhexyl-2,3,4,5-
tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (BEH-
TEBP)] and a suite of isopropylated aryl phosphates and triphenyl phosphate. Research from 
our laboratory, as well as other research groups, has shown that FM550 components are 
widely detected in foams from baby products [9] and sofas [3], as well as house dust [10–
12]. Toxicological effects are relatively unknown, but in vitro studies have shown that EH-
TBB and BEH-TEBP are potential endocrine disruptors [13]. Further, a recent rat study 
showed that perinatal exposure to FM550 resulted in obesity, anxiety, and early puberty [14].
Such market shifting of compounds, which can be expected to continue, suggests the need 
for comprehensive analytical methods to measure legacy PBDEs and their hydroxylated 
metabolites, as well as novel FRs in human tissues (i.e., serum). Most techniques for the 
analysis of PBDEs and OH-BDEs in human serum are based on those originally described 
by Hovander et al. [15]. This latter method involves protein denaturation with a strong acid, 
liquid-liquid extraction, separation of the OH-BDEs from the PBDEs by an alkaline wash, 
derivatization of the OH-BDEs by diazomethane (or another agent), silica or acid silica gel 
clean-up, and instrumental analysis by gas chromatography-mass spectrometry (GC-MS) [8, 
16–19]. In recent years, liquid chromatography tandem mass spectrometry (LC-MS/MS) has 
been used for OH-BDE and bromophenol analysis [20–24], but with limited application to 
human serum [25].
Liquid-liquid extraction methods require large volumes of organic solvents and typically use 
diazomethane as the derivatizing agent, which is a potential hazard. Alternatively, solid-
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phase extraction (SPE) techniques have been developed to assist in the isolation of 
halogenated organic compounds (e.g., PCBs, PBDEs) and their hydroxylated metabolites, as 
well as halogenated phenols (e.g., brominated phenols, triclosan) [7, 26–30], in 
environmental matrices. However, these methods rely on derivatization for hydroxylated- 
and phenol-compound instrumental analysis by GC-MS. To our knowledge, no published 
method exists that can recover and quantify PBDEs, OH-BDEs, tribromophenols (TBPs), 
EH-TBB, BEH-TEBP, and HBCDs in serum samples.
The present study developed a novel SPE extraction technique for the analysis of PBDEs, 
OH-BDEs, HBCDs, TBPs, EH-TBB, and BEH-TEBP in human serum. Specifically, our 
method uses dichloromethane (DCM): ethyl acetate to initially elute the analytes from the 
SPE cartridge, producing a cleaner extract. Additional purification of the extract and 
fractionation is performed using non-acidified silica, allowing for conservation of acid-labile 
compounds such as BEH-TEBP. Finally, our method is capable of analyzing TBPs, EH-
TBB, and BEH-TEBP. Representative structures are shown in Fig. 1. PBDEs, TBPs, EH-
TBB, and BEH-TEBP were analyzed by GC-MS, and OH-BDEs and HBCDs were analyzed 
by LC-MS/MS. The developed method was then applied to 43 serum samples collected in 
2010–2011 from a pregnancy cohort in Durham County, NC, USA, to evaluate the detection 
frequency and distribution of these analytes.
Materials and methods
Chemicals
All solvents used were HPLC-grade or better (EMD Millipore Corporation, Billerica, MA). 
The PBDE calibration standard was prepared from 27 PBDE individual congeners 
(AccuStandard, New Haven, CT). Standard solutions of α-, β-, and γ-
hexabromocyclodecane (HBCD, 99 %), 13C-α-,β-, and γ-HBCD, 13C-BDE 209 (2, 2′, 3, 
3′, 4, 4′, 5, 5′, 6, 6′-BDE, 99 %), 13C-OH BDE 100 (3-OH 2,2′,4,4′,6-BDE, 99 %), 13C-6-
OH BDE 47 (6-OH 2,2′,4,4′-BDE, 99 %), 2,4,5-TBP and 2, 4,6-TBP were purchased from 
Wellington Laboratories (Guelph, ON). 3-OH BDE 47 (3-OH 2,2′,4,4′-BDE, 97 %), 6-OH 
BDE 47 (100 %), 4′-OH BDE 49 (4′-OH 2,2′,4,5′-BDE, 97.8 %), 5′-OH BDE 99 (5′-OH 
2,2′,4,4′,5-BDE, 99.0 %), 6′-OH BDE 99 (6′-OH 2,2′,4,4′,5-BDE, 99.3 %) and F-BDE 69 
(4′-fluoro-2,3′4,6-tetrabromodiphenyl ether) were purchased from AccuStandard. 13C-CDE 
141 (2,2′-3,4, 5,5′-hexachlorinated diphenyl ether, 99 %) was purchased from Cambridge 
Isotope Laboratories (Andover, MA). Formic acid (98 %) was purchased from Sigma-
Aldrich.
Sample collection
Serum samples were collected as part of the Healthy Pregnancy, Healthy Baby Study 
(HPHB) cohort (n = 43) in Durham County, NC, USA. These samples all came from one 
clinic site: Lincoln Community Health Center, a federally qualified health center serving 
primarily low-income populations. A group of samples from the HPHB cohort were 
previously analyzed to investigate the association between PBDEs, OH-BDEs, and thyroid 
hormones [25]. However, the samples analyzed in the present study were from a separate 
group of individuals within the HPHB cohort. Serum samples were collected between 
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September 2008 and June 2010 during a routine clinic visit in either the second (24–28 
weeks of pregnancy) or third trimester (35–36 weeks). Full details regarding participant 
recruitment and sample collection have been described previously [25]. In brief, all 
participants were residents of Durham County in central NC, USA. In our cohort of 43 
samples, their average age was 24.3 years (range, 18–36 years), and 55 % reported 
completing some college. Further, our cohort was predominately non-Hispanic black (60 %), 
followed by non-Hispanic white (17.5 %), and Hispanic (15 %) (demographic data was not 
available for 1 individual). Blood was collected in a clinical laboratory, allowed to sit on ice 
and clot, and then serum was isolated by centrifugation (5 min, 3500 rpm). Serum samples 
were kept frozen (−20 °C) until analysis. Sample collection and handling was performed 
according to the human subject research protocol approved by the Duke University 
Institutional Review Board.
Sample extraction and analysis
Serum was thawed and gravimetrically transferred (~3.0–4.0 g) to a glass test tube. All 
glassware was baked-out overnight (450 °C) and rinsed with DCM and hexane prior to use. 
Internal standards were spiked (2.5 ng of F-BDE 69 and 13C-BDE 209; 1 ng of 13C-6-OH 
BDE 47 and 13C-α-,β-, γ-HCBD) prior to the serum addition. Formic acid (2 ml) and water 
(6 ml) were added to denature the serum proteins and the mixture was sonicated for 20 min. 
The analytes were isolated on a Waters Oasis HLB column (500 mg, 6 ml). The column was 
conditioned with 5 ml each of dichloromethane (DCM), methanol (MeOH), and water; the 
sample was loaded, and the column washed with 5 ml water. The analytes were eluted with 
10 ml of DCM:ethyl acetate, with the eluent blown to near dryness under a gentle nitrogen 
stream and reconstituted in 1 ml of hexane. The analytes were cleaned and fractionated 
using a silica column (1 g, Waters, Sep-Pak) that was initially conditioned with 10 ml of 
hexane. The first fraction was eluted with 10 ml of hexane, reduced in volume to ~100 μl, 
and analyzed by GC-MS for a suite of 27 PBDEs and 2,4,5- and 2,4,6-TBP. Prior to 
analysis, 5 ng of 13C-CDE 141 was spiked to assess F-BDE 69 recovery. The second 
fraction was eluted with 10 ml of DCM, blown to dryness, reconstituted in ~100 μl MeOH 
and analyzed by LC-MS/MS for the HBCDs and OH-PBDEs. After LC-MS/MS analysis, 
the MeOH fractions were solvent switched to hexane, 5 ng of 13C-TBB added, and analyzed 
for EH-TBB and BEH-TEBP by GC-MS.
Instrumental analysis was performed using methods previously developed by our laboratory 
[25, 31]. The GC-MS was operated in electron capture negative ionization mode. The LC-
MS/MS conditions were altered slightly and are briefly described. Analytes were separated 
using a C18 column (Agilent Zorbax Eclipse XDB-C18, 4.6 × 50 mm, 1.8 μm particle size) 
under gradient conditions and mobile phases were water and acetonitrile (ACN), both 
modified with 5 mM acetic acid. Initial conditions were 40:60 water:ACN, held for 1 min, 
increased to 10:90 over 0.5 min, increased to 5:95 over 4.0 min, held for 0.5 min, returned to 
initial conditions over 0.25 min, and held for 4.25 min. The column temperature was 40 °C, 
the injection volume was 20 μl and flow rate was 400 μl/ml. The internal standards 
were 13C-α HCBD for the HBCDs and 13C-6-OH BDE 47 for the OH-BDEs. The multiple 
reaction monitoring transitions (MRMs) observed for the OH-tetraBDEs were m/z 500.7 > 
418.8, m/z 500.7 > 265.9 and m/z 500.7 > 78.9. MRMs monitored for the OH-pentaBDEs 
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were m/z 580.7 > 498.8, m/z 580.7 > 343.8, and m/z 580.7 > 78.9. We found that the 
position of the hydroxyl group gave diagnostic MRMs, as has been shown by other 
researchers [24]. For example, the m/z 500.7 > 418.8 and m/z 580.7 > 498.8 (formation of 
[M-Br]-) was unique to meta-OH BDEs. Also, the m/z 500.7 > 265.9 and m/z 580.7 > 343.7 
(formation of the bromobenzoquinone) was indicative of para-OH BDEs. Finally, the ortho-
OH BDEs showed only the m/z 500.7 > 78.9 and m/z 580.7 > 78.9 transitions (formation of 
Br-). In addition to retention time, these diagnostic MRMs were used to positively identify 
the OH-BDEs. The following OH-BDEs were quantified: 4′-OH BDE 49, 3-OH BDE 47, 6-
OH BDE 47, 6′-OH BDE 99, and 5′-OH BDE 99. MRM chromatograms for a 0.1 ng 
standard (10 pg on-column) are shown in the Electronic Supplementary Material (ESM) 
(Fig. S1).
Lipid determination
Serum triglycerides (TG) and total cholesterol (CHOL) were determined using enzymatic 
techniques (Duke University Health System Clinical Laboratories, Durham, NC). The serum 
lipid content (TL) was estimated using the previously reported correlation equation, TL = 
1.33 × TG + 1.12 × CHOL + 1.48 (g/l) [32].
Quality control
Fetal bovine serum (PAA Laboratories, Etobicoke, ON) and deionized water were both used 
as laboratory blanks. Method detection limits (MDLs) were calculated as three times the 
standard deviation of the laboratory blanks. Analytes levels were similar in both the fetal 
bovine serum and the deionized water and therefore both matrices were used for the MDL 
calculations. If analytes were not detected in the blanks, then the MDL was quantified as 
three times the standard deviation of the baseline noise. The only analytes detected in the 
laboratory blanks were BDE 47 (mean = 890 pg/g lw), BDE 99 (380 pg/g lw), BDE 100 
(585 pg/g lw), and 6-OH BDE 47 (440 pg/g lw). For PBDEs, the accuracy of the developed 
method was tested by analyzing SRM 1958 [Fortified Human Serum; NIST (National 
Institute of Standards and Technology), Gaithersburg, MD].
Data analysis
Statistical analysis was performed using JMP® Pro (v. 11.0.0, 2013, SAS Institute Inc., Cary, 
NC). Values below MDL were assigned a value of half the detection limit for statistical 
analysis only. Summary statistics were only calculated for those variables with detection 
frequencies >50 %. Analyte data were assessed for normality using the Shapiro-Wilkes test 
and log-transformed as necessary. Correlations among analytes, and between serum lipid 
level and analyte concentrations, were examined using the Spearman rank-order correlation. 
Statistical significance was set at alpha < 0.05.
Results and discussion
General method development
Our SPE extraction methods were adapted from previous techniques using Oasis HLB SPE 
columns for the extraction of PBDEs, HBCDs, and OH-BDEs from serum [27–29, 33]. A 
flow chart of the developed method is shown in Fig. 2. Due to the range of analyte polarity, 
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selection of an appropriate elution solvent was critical to elute the analytes only and avoid 
matrix co-elution. DCM was not sufficiently polar to extract the OH-BDEs from the HLB 
column, but was sufficient for PBDEs, HBCDs, EH-TBB, and BEH-TEBP (data not shown). 
Whereas other studies have used 1:1 DCM:MeOH as the elution solvent, we found that this 
solvent mixture eluted the serum matrix from the column. In particular, the matrix co-elution 
caused severe signal suppression and poor peak shape for the OH-BDEs and HBCDs during 
the LC-MS/MS analysis. Instead, we used 1:1 DCM:ethyl acetate to elute the target analytes. 
This elution mixture was sufficient to elute the polar analytes, while eluting a minimal 
amount of matrix.
Additional extract clean-up and analyte fractionation was performed using a silica gel SPE 
column. Previous studies have used sulfuric acid silica gel columns to clean the serum 
matrix, but in our experiments the use of acidic silica resulted in the near complete loss of 
BEH-TEBP (~5 % recovery, n = 3). Further, aggressive cleaning techniques were not 
required since very little matrix was eluted by the DCM:ethyl acetate. The first fraction 
(hexane) only contained the PBDEs; additional fractions with 1:1 DCM:hexane and DCM 
did not elute additional PBDEs. The OH-BDEs, HCBDs, EH-TBB, and BEH-TEBP were 
eluted in 1:1 DCM:hexane. Additional tests demonstrated equal extraction efficiency using 
DCM as the eluant, and thus DCM was selected due to the higher polarity.
Spike and recovery
Method performance was assessed by spiking 1–2 ng of all analytes (PBDEs, 2,4,6-TBP, α-
HBCD, and OH-BDEs) into 3 ml of fetal bovine serum (Table 1). Overall, the method 
showed excellent recovery for the tri- to hexa-BDEs, with a mean recovery of 81 % (range, 
61–106 %). The octa- and nona-BDE congeners showed lower recovery (mean, 55 %, range, 
40–61 %), demonstrating that the method was not as efficient at capturing the higher 
brominated BDEs which is consistent with previous studies [34]. Further, BDE 209 was not 
recovered in the method. The 2,4,6-TBP, α-HBCD, EH-TBB, BEH-TEBP, and OH-BDEs 
generally showed >90 % recovery, but the tetra-OH BDE recovery was slightly lower, 
ranging from 59–75 %.
Standard reference material
Method accuracy for PBDEs was assessed by extracting NIST Standard Reference Material 
(SRM) 1958 (Fortified Human Serum). Most of the PBDEs showed good accuracy: ranging 
from 67 % (standard error = 2.9 %) for BDE 99 to 99 % (5.2 %) for BDE 154, with the 
exception of BDE 153 (mean recovery = 46 %, SE = 2.4 %) (Table 2). However, the method 
showed poor accuracy for the lower brominated (i.e., BDE-17) and higher brominated (i.e. 
BDE-183) congeners. Overall, these results suggest that the method developed was 
satisfactory for most tri- through hepta-BDE congeners.
Method application to maternal serum
Associations between serum lipid and flame retardant levels—Hydrophobic 
organic compounds tend to partition into the lipid component of tissues. As a result, 
normalizing the serum chemical concentrations by the total serum lipid level [35] has been 
suggested, and this approach is typically used in the literature [6, 36]. To our knowledge, 
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though, very few studies actually report lipid content-organic contaminant correlations [37]. 
In our cohort, the lipid content was not correlated with the predominate BDE congeners or 
2,4,6-TBP (BDE-47: p = 0.60; BDE-99: p = 0.64; BDE-100: p = 0.43; BDE-153: p = 0.75; 
BDE-154: p = 0.69; sum-BDE: p = 0.58; 2,4,6-TBP: p = 0.27). To be consistent with the 
literature, we are here reporting values in ng/g lipid weight (ng/g lw). However, the non-
lipid-normalized values are presented in the supporting information.
PBDEs—Seven of the 27 PBDE congeners were detected above the MDL in the 43 
maternal serum samples, and at least 1 PBDE was detected in every sample (Table 3). The 
congeners frequently detected included: BDE 28/33, 47, 99, 100, 153, 154, and 183. Total 
PBDEs ranged from 0.71–252 ng/g lipid in the serum samples. Total PBDEs, BDE-47, 
BDE-100, and BDE-99 were log-normally distributed, but BDE-154 and BDE-153 were 
neither normally nor log-normally distributed.
BDE-47 was the most abundant congener, contributing approximately 50 % of the total BDE 
burden in the serum samples. BDE-47 was detected in 98 % of samples with a geometric 
mean of 13.4 ng/g lipid (95 % confidence interval, 10.0–18.1). The second most abundant 
congeners were BDE-153 and BDE-99, with geometric mean levels of 3.8 ng/g lipid (95 % 
CI, 2.8–5.2) and 3.6 ng/g lipid (95 % CI, 2.6–5.1), respectively. These PBDE levels and 
patterns were similar to those previously reported for this cohort, with the exception of 
BDE-153, which was lower in the current study [25]. The lower BDE-153 levels are 
presumably due to the low method accuracy as reflected in the SRM 1958 sample analysis. 
In addition, the PBDE congener patterns in the current study are similar to those from other 
regions of North America [6, 7].
PBDE levels from the current North Carolina cohort were lower than those reported in the 
2003–2004 National Health and Nutrition Examination Survey (NHANES) from the USA 
[36]. The NHANES 2003–2004 dataset is the most recent national representative dataset for 
which samples were analyzed on the individual level. For example, the 2003–2004 
NHANES 20–39 year age group levels were 1.6-fold and 1.4-fold lower in the more recent 
North Carolina cohort for BDE-47 and BDE-99, respectively. The NHANES cohort includes 
individuals from diverse race/ethnicity groups, whereas our cohort was predominantly 
African-American. However, PBDE levels in the NHANES non-Hispanic Black, female 
sub-group were higher than those of the overall pooled mean for the full NHANES sample, 
suggesting that racial/ethnic differences were not responsible for the higher NHANES 
levels. The North Carolina cohort was collected at a significantly later time period (2008–
2010), and PBDE serum levels have generally shown decreasing trends in the USA since the 
early 2000s [7, 38], which may explain some of the variability between the NHANES and 
NC samples. In addition, differences in the geographic scope of study areas and the 
representation of low-income individuals between the cohorts may be responsible for the 
observed differences. Similarly, PBDE serum levels from the 2007–2009 Canadian Health 
Measures Survey (20–39 year group) were 1.6-fold higher for both BDE-47 and BDE-99, 
respectively [6]. Again, these differences may be driven by geographic, temporal, or 
socioeconomic differences.
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OH-BDEs and TBPs—Five OH-BDE congeners were monitored in the present study, but 
only 5′-OH BDE 99 and 4′-OH BDE 49 were detected in >50 % of the samples. Geometric 
mean levels were 0.062 ng/g lw and 0.029 ng/g lw for 5′-OH BDE 99 and 4′-OH BDE 49, 
respectively. These levels were 1–2 orders of magnitude lower than the PBDEs; this finding 
is consistent with previous studies in human serum [8, 19, 25, 38]. The 4′-OH BDE 49 
levels in our cohort (geometric mean = 29 pg/g lw) were somewhat lower than those 
reported from a different subset of the study cohort (geometric mean = 110 pg/g lw) [25]. It 
is difficult to directly compare the OH-BDE levels in our study to those from other regions 
since most report levels on ng (or pg) per ml basis. However, comparing wet weight 
concentrations (ESM Table S1) shows that the 4′-OH BDE 49 and 5′-OH BDE 99 levels in 
our cohort were ~10- to 60-fold lower than from other regions in the USA [8, 38, 39]. The 
higher concentrations in the previously published studies [38, 39] may be due to the fact that 
the cohorts were from California, which is known to have higher PBDE exposure due to 
California Technical Bulletin 117.
2,4,6-TBP was detected in 100 % of samples, but 2,4, 5-TBP was not detected in any 
sample. Interestingly, the levels of 2,4,6-TBP were greater than individual PBDE congeners. 
For example, the 2,4,6-TBP geometric mean was 19.2 ng/g lw and the BDE-47 geometric 
mean was 13.4 ng/ g lw. Although studies are limited, 2,4,6-TBP has also been reported in 
serum from Japan [40], Hong Kong [19, 41], Norway [42], Pakistan [27], northern Quebec 
[43], and the USA [16]. However, reported 2,4,6-TBP concentrations vary greatly among 
studies. For example, Qui et al. [16] reported mean 2,4,6-TBP levels of 0.8 ng/g lw in 
maternal serum from Indiana in 2003–2004, ~25-times lower than our study. 2,4, 6-TBP 
exposure is not well understood, but can originate from multiple sources. 2,4,6-TBP is used 
as a flame retardant and is an intermediate in the production of other flame retardants 
chemicals [44]. For example, 2,4,6-TBP was recently detected in a novel brominated 
triazine-based flame retardant—2,4, 6-tris(2,4,6-tribromophenoxy-1,3,5-triazine (TTBP-
TAZ), a compound used in various electronics plastics [45]. As such, 2,4,6-TBP has been 
detected near e-waste sites [46], as well as in indoor air [47]. In addition, 2,4,6-TBP is 
formed naturally in marine algae [48] and sponges [49] and can bioaccumulate in higher 
trophic level marine mammals [49]. Finally, 2,4, 6-TBP could also be formed through the 
metabolism of certain PBDEs, in a mechanism similar to the formation of 2,4, 5-TBP from 
BDE-99 [50, 51].
HBCDs—HBCDs were infrequently detected (7 % of individuals), with only the α-HBCD 
isomer observed (range, <0.02–3.0 ng/g lw). Dominance of the α-HBCD isomer in serum is 
consistent with previous studies with the exception of a recent study from South Korea that 
showed the γ-HBCD as the dominant isomer. HBCDs are widely detected in house dust, at 
levels comparable to PBDEs [5], suggesting that the low serum levels may be due to poor 
uptake or rapid metabolism. Overall, there are few literature reports of HBCDs in human 
serum, but levels are generally within the range observed in the present study [6, 52–54]. In 
contrast to our findings, a recent Canadian study observed 100 % detection of α-HBCD and 
23 and 35 % detection of β- and γ-HBCD, respectively (geometric mean ΣHBCD = 0.85 
ng/g lipid) [6].
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EH-TBB and BEH-TEBP—EH-TBB and BEH-TEBP were not detected in any serum 
sample, but these analytes had relatively high MDLs (56, 000 pg/g lw for EH-TBB and 
24,000 pg/g lw for BEH-TEBP). To our knowledge, only one other study has investigated 
EH-TBB and BEH-TEBP in human serum [55] . The previously reported cohort comprised 
nursing women from Quebec, Canada and collected samples in 2008–2009 (n = 102). The 
detection frequencies for the Quebec cohort were 57 % for EH - TBB (geometric mean 
concentration = 1300 pg/g lw) and 17 % for BEH-TEBP (geometric mean not reported) [55]. 
Although exposure to EH-TBB via house dust appears to be ubiquitous [3, 5], EH-TBB is 
rapidly metabolized to TBBA [56] which may explain the non-detect serum levels in our 
cohort.
Associations between PBDEs, OH-BDEs, and 2,4,6-TBP—Considering the lipid 
normalized concentrations, all PBDEs and ΣPBDE were highly correlated with Spearman 
rank correlation coefficients ranging from 0.40–0.95 (p < 0.05 for all relationships) (Fig. 3 
and Table 4). Since the lipid levels were not associated with the PBDE and 2,4,6-TBP levels 
in our cohort, Spearman coefficients were also calculated using non-lipid normalized 
concentrations and negligible differences were observed. These trends suggest a common 
exposure source such as house dust [57]. Further, 4′-OH BDE 49 and 5′-OH BDE 99 were 
correlated with most BDEs. A notable exception was that 5′-OH BDE 99 was not correlated 
with BDE 99 (p = 0.14). This was unexpected considering that 5′-OH BDE 99 is metabolite 
of BDE 99 [50]. As well, 2,4, 6-TBP and the PBDE/ ΣPBDE congeners were correlated with 
the exception of BDE-47. These relationships were not as strong as among the individual 
PBDE congeners. This may indicate multiple exposure sources or that some of the PBDEs 
are metabolizing to 2,4,6-TBP. To our knowledge, this is the first report describing the 
relationships between 2,4,6-TBP and PBDE congeners in blood. However, a recent study 
from a Hong Kong cohort showed a positive relationship between Σ 2,4,6-TBP-glucuronide 
and sulfate conjugates in urine and Σ 2,4,6-tribromo-BDEs in human serum [41].
Conclusions
A comprehensive analytical method was developed to measure legacy PBDEs and their 
hydroxylated metabolites, as well as HBCDs, EH-TBB, and BEH-TEBP in human serum. 
The nearly ubiquitous detection of PBDEs in serum indicates that, despite their phase-out in 
the mid-2000s and 2013, PBDEs continue to be present in human tissues. Future monitoring 
is essential. In addition, two metabolites of PBDEs—5′-OH BDE 99 and 4′-OH BDE 47—
were broadly detected. 2,4,6-TBP was ubiquitously detected at levels that were generally 
greater than individual PBDE congeners. The detection of OH-BDEs and 2,4,6-TBP is 
important because these compounds have been shown to inhibit thyroid hormone regulating 
enzymes, with potencies greater than the PBDEs [58, 59]. There are very few reports of 
2,4,6-TBP in human serum; future monitoring should be expanded to include this 
compound. Finally, as newer and alternative flame retardants are introduced into the 
marketplace, existing analytical techniques will need to be modified to expand monitoring 
programs.
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Fig. 1. 
Representative chemical structures for target analytes
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Fig. 2. 
Flow chart of extraction and analysis methods
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Fig. 3. 
Scatter plot 2,4,6-TBP versus ΣBDEs in serum from the HPHB cohort in North Carolina 
using a lipid normalized and b non-lipid normalized concentrations
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Table 1
Analyte recovery (%) in fetal bovine serum matrix spikes
Mean Std Error
BDE 30 87 3
BDE 17 97 5
BDE 25 106 4
BDE 28,33 82 3
BDE 75 74 6
BDE 49 n/a n/a
BDE 71 85 1
BDE 47 71 6
BDE 66 90 6
BDE 100 79 6
BDE 119 81 5
BDE 99 61 5
BDE 116 83 4
BDE 85,155 79 5
BDE 154 75 5
BDE 153 74 5
BDE 138 81 5
BDE 156 77 5
BDE 183 60 4
BDE 191 57 4
BDE 181 59 3
BDE 190 61 3
BDE 203,200 53 9
BDE 205 40 2
EH-TBB 111 4
BEH-TEBP 101 5
2,4,6-TBP 93 5
α-HBCD 87 15
5′-OH BDE 99 94 7
6-OH BDE 99 89 4
3-OH BDE 47 64 8
4′-OH BDE 49 59 3
6-OH BDE 47 75 0.3
n = 5 for PBDEs; n = 3 for EH-TBB, BEH-TEBP, 2,4,6-TBP, α-HBCD and OH-BDEs
Spike levels: PBDEs, EH-TBB, BEH-TEBP = 1–2 ng; 2,4,6-TBP = 2 ng; α-HBCD and OH-BDEs = 1 ng
For the FBS matrix spikes only, BDE 49 and BDE 71 co-eluted and could be quantified separately
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Table 2
Method performance (percent accuracy) for PBDEs in NIST SRM 1958
SRM 1 SRM 2 SRM 3 Mean (SE)
BDE 17 51 51 60 54 (3.2)
BDE 28/33 80 80 88 82 (2.6)
BDE 47 76 77 85 80 (2.8)
BDE 66 74 79 86 79 (3.5)
BDE 100 71 74 85 77 (4.1)
BDE 99 64 64 73 67 (2.9)
BDE 85/155 69 75 82 75 (3.8)
BDE 154 90 100 107 99 (5.2)
BDE 153 42 45 50 46 (2.4)
BDE 183 20 25 25 23 (1.4)
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